Navigation Links
JCI early table of contents for May 24, 2013
Date:5/24/2013

h

Dysregulated gene expression is a feature of most cancers. In this issue of the Journal of Clinical Investigation, Gal Markel and colleagues at Chaim Sheba Medical Center in Ramat-Gan, Israel, demonstrated that expression of the RNA editing enzyme ADAR1 is frequently reduced in melanoma that was linked to the development of metastases. Loss of ADAR1 enhanced the growth and tumor-forming ability of the melanoma cells. Markel and colleagues found that ADAR1 normally regulates the expression of microRNAs, molecules that help to control the expression of specific genes. In turn, microRNAs also control the expression of ADAR1. These studies demonstrate that loss of an RNA editing enzyme contributes to the development of a more aggressive, metastatic form of melanoma.

TITLE:
MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth

AUTHOR CONTACT:
Gal Markel
Chaim Sheba Medical Center, Ramat-Gan, ISR
Phone: 972-3-5304591; E-mail: markel@post.tau.ac.il

View this article at: http://www.jci.org/articles/view/62980?key=96ee313210f0982ab94b


'/>"/>

Contact: Jillian Hurst
press_releases@the-jci.org
Journal of Clinical Investigation
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8

Related biology news :

1. Artificial womb unlocks secrets of early embryo development
2. Mid-Atlantic suburbs can expect an early spring thanks to the heat of the big city
3. An early spring drives butterfly population declines
4. Hazy shades of life on early Earth
5. American Society of Plant Biologists honors early career women scientists
6. Early warning system for seizures could cut false alarms
7. A new gene thought to be the cause in early-onset forms of Alzheimers disease
8. Promising developments in early diagnosis and treatment of mesothelioma
9. Early detection techniques offer hope for improved outcomes in lung cancer patients
10. New study links air pollution and early death in the UK
11. Attendees Save Up To $800 on Boston-area Pharmaceutical and Healthcare Conferences, Early Bird Discounts Expiring April 27
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2015)... June 24, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced that Sharp has selected its ... authentication for its latest flagship smartphone device, the ... 200 million shipments of its fingerprint ID sensor ... strength, scalability and leadership in the biometrics market ...
(Date:6/23/2015)... , June 22, 2015 ... announced the addition of the "Body-Worn Temperature ... Growth, Trends and Forecast 2014 - 2020" ... offers strategic analysis of the global body-worn temperature ... has been segmented on the basis of types, ...
(Date:6/18/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... commerce market announces that its Wocket® smart wallet will be ... Mark", scheduled to air on WABC Radio (am770) in ... The broadcast air- time for the extensive ... NXT-ID, Inc.,s CEO Gino Pereira will be discussing ...
Breaking Biology News(10 mins):Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2Body-Worn Temperature Sensors Market - Global Industry Analysis 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3
... Armas, a mining engineer from the central Philippines, discovered some ... phosphate. Forty years later, Dr. Hamilcar Intengan, a friend of ... the bones and donated them to The Field Museum. , ... individuals, science might never have documented what has turned out ...
... the Monell Chemical Senses Center report that bitter taste ... variants of taste genes and the presence of naturally-occurring ... the September 19 issue of Current Biology. , Scientists ... defense mechanism to detect potentially harmful toxins in plants. ...
... Ever wondered how ants find their way straight to ... discovered how the humble wood ant navigates over proportionally ... and changing natural landmarks. The research could have significant ... furthering our understanding of basic animal learning processes. ...
Cached Biology News:New dwarf buffalo discovered by chance in the Philippines 2New dwarf buffalo discovered by chance in the Philippines 3New dwarf buffalo discovered by chance in the Philippines 4Bitter taste identifies poisons in foods 2How ants find their way 2
(Date:6/30/2015)... ... June 30, 2015 , ... The maximum number of shares proposed to be ... (including shares of unvested restricted stock). On June 29, 2015, the last trading day ... shares reported on the OTCBB was $2.29 per share. , The tender offer will ...
(Date:6/30/2015)... 2015  Custom Computer Specialists, Inc. ("Custom"), a leading ... silver sponsors of the Primary Care Development Corporation,s ("PCDC") ... lending their support of PCDC,s mission to expand access ... its founding in 1993, PCDC has been a key ... has financed over 100 completed primary care projects, valued ...
(Date:6/30/2015)... ... June 30, 2015 , ... Southern Illinois ... the position of vice president of instruction at Chippewa Valley Technical College (CVTC) ... appreciated the opportunity to lead SIUE during the past three years,” Furst-Bowe said. ...
(Date:6/29/2015)... ... , ... This cutting edge standard making is a madatory tool for use ... WAV-8 is the world’s first cuvette-shaped, solid-state filter that lets metrologists and quality control ... spectrophotometer calibration standards, such as those made from didymium glass were only able to ...
Breaking Biology Technology:Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 3Custom Computer Specialists Announces Sponsorship Of The Primary Care Development Corporation's Corporate Circle 2SIUE’s Furst-Bowe Accepts VP of Instruction at CVTC 2SIUE’s Furst-Bowe Accepts VP of Instruction at CVTC 3FireflySci Releases Spectrophotometer Calibration Standards for NIR Wavelength Accuracy Verification 2FireflySci Releases Spectrophotometer Calibration Standards for NIR Wavelength Accuracy Verification 3
... JOLLA, Calif., March 26 TorreyPines,Therapeutics, Inc. (Nasdaq: ... and year ended December 31, 2007. For the full ... a net loss of $23.4 million.,Cash and cash equivalents ... made meaningful progress in our three clinical development programs,in ...
... 26 PharmAthene, Inc.,(Amex: PIP ) ... and,commercialization of medical countermeasures against chemical and,biological ... awarded a contract,modification providing an additional value ... the Company,s broad spectrum chemical nerve,agent prophylaxis., ...
... Aeterna Zentaris Inc.,(NASDAQ: AEZS ; TSX: AEZ), ... oncology, today reported dosing has commenced with,its flagship ... (LHRH) antagonist, in the second efficacy study,of its ... a,non-cancerous enlargement of the prostate., "We are ...
Cached Biology Technology:TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights 2TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights 3TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights 4TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights 5TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights 6TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights 7Department of Defense Awards $5.8 Million Contract Modification Providing Additional Funding for PharmAthene's Protexia(R) Program 2Department of Defense Awards $5.8 Million Contract Modification Providing Additional Funding for PharmAthene's Protexia(R) Program 3Department of Defense Awards $5.8 Million Contract Modification Providing Additional Funding for PharmAthene's Protexia(R) Program 4Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia 2Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia 3Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia 4
... Custom design, The Bioactive peptides are molecules ... a biological behaviour or activity which can ... pharmaceutical, diagnostic, chemical and agro-food applications. In ... modified peptides with superior properties for therapeutic ...
... (enzyme-lined immunospot) Kit analyzes interferon gamma (IFNγ) ... spot forms at the site where secreted ... a dissection microscope or automated ELISPOT reader) ... cells added to the microplate. This allows ...
... DNAscope is an integrated confocal laser scanner ... integrated into your specific application. GeneFocus can ... tailor the system to your specifications. ... design has been modularized and built onto ...
... Professional 4200A can be upgraded to the ... loads, scans, analyzes, and saves results for ... by email when the batch is complete. ... for warped slides. GenePix Pro gives you ...
Biology Products: